CureVac racks up $110 mln
German biopharmaceutical company CureVac has closed $110 million in funding. The investors included Baillie Gifford, Chartwave Limited, the Coppel family, Elma Investments Ltd, Sigma Group and the Bill & Melinda Gates Foundation.
3 November 2015•4 mins read
